Abstract
Over the last decade, a host of sex differences have been elucidated in the realm of cardiovascular disease (CVD), including both its presentation and response to treatment. It has been suggested that the term ‘ischemic heart disease’ be used in preference to ‘coronary heart disease’ when referring to CVD in women, due to the fact that women, even when symptomatic, have lower amounts of obstructive plaque than do men. However, more than 80% of middle-aged women have one or more standard (and numerous novel) CVD risk factors. This review will focus primarily on lipid/lipoprotein biology and plasma concentrations in women, beginning in the fetus and extending through childhood, adolescence, pregnancy, midlife and postmenopausal periods.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
